TaiRxROCO:6580 74 OCF Margin % is -476.13% as of Dec. 2025. GuruFocus rates ROCO:6580 with a GF Score™ of 74/100 and a GF Value™ of NT$107.47 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 950 Biotechnology companies, TaiRx ranks worse than 76.11% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. TaiRx's Cash Flow from Operations for the
six
months ended in Dec. 2025 was NT$-96.99 Mil. TaiRx's Revenue for the
six
months ended in Dec. 2025 was NT$20.37 Mil. Therefore, TaiRx's OCF Margin % for the quarter that ended in Dec. 2025 was -476.13%.
The historical rank and industry rank for TaiRx's OCF Margin % or its related term are showing as below:
ROCO:6580'
s OCF Margin % Range Over the Past 10 Years
Min: -12302.13 Med: -3258.33 Max: -640.27
Current: -640.27
During the past 11 years, the highest OCF Margin % of TaiRx was -640.27%. The lowest was -12302.13%. And the median was -3258.33%.
ROCO:6580's OCF Margin % is ranked worse than 76.11% of 950
companies
in the Biotechnology industry
Industry Median: -65.71
vs ROCO:6580: -640.27
TaiRx OCF Margin % Related Terms
TaiRx OCF Margin % Historical Data
* Premium members only.
The historical data trend for TaiRx's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6580 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, TaiRx's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiRx OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TaiRx's OCF Margin % distribution charts can be found below:
* The bar in red indicates where TaiRx's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiRx (ROCO:6580) has a OCF Margin % of -476.13% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TaiRx and its competitors. According to the industry distribution chart, TaiRx ranks #723 out of 950 companies in the Biotechnology industry, placing it in the top 76.1%.
Is TaiRx's OCF Margin % too high?
TaiRx's current OCF Margin % is -476.13%. Based on the distribution chart, TaiRx ranks #723 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TaiRx has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiRx's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TaiRx ranks #723 out of 950 companies for OCF Margin %. This places TaiRx in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TaiRx and its competitors. TaiRx's current OCF Margin % is -476.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiRx stock overvalued right now?
Based on GuruFocus' analysis, TaiRx (ROCO:6580) is currently considered Possible Value Trap. The stock's GF Value™ is NT$107.47, compared to a current price of NT$13.05 — trading 87.9% below its estimated fair value. The current OCF Margin % is -476.13%. TaiRx's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TaiRx (ROCO:6580), the current OCF Margin % is -476.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiRx (ROCO:6580) Overvalued in 2026?
Based on GuruFocus' analysis, TaiRx stock appears to be undervalued.
The current stock price of NT$13.05 is trading 87.9% below its estimated GF Value™ of NT$107.47.
GuruFocus considers TaiRx to be Possible Value Trap.
Key valuation signals for ROCO:6580:
OCF Margin %: -476.13%
GF Value™: NT$107.47 vs. price of NT$13.05 (87.9% below fair value)
No single metric tells the full story. See the ROCO:6580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drugs and improves current standard treatments to promptly find cures for diseases and fulfill unmet medical needs. The company focuses on new drug development for Asia and other markets.
74GF Score
Get the complete analysis for ROCO:6580
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6580 has been successfully added to your 
